TAMMY STIMMERMAN: Open Payments
NPI 1730691320 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 21 payments from 9 companies in 2025. Trend: 2023 $302 · 2024 $536 · 2025 $482
Food & beverage: $482
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $85 |
| Lilly USA, LLC | 4 | $81 |
| Sumitomo Pharma America, Inc. | 3 | $78 |
| Novo Nordisk Inc | 4 | $70 |
| PFIZER INC. | 2 | $54 |
| Medtronic, Inc. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $20 |
Products named: Kerendia, GEMTESA, MOUNJARO, Wegovy, INCEPTIV, ELIQUIS, FARXIGA, AREXVY.
Industry payments across FL — which companies pay providers there.
